Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06277323 · ClinicalTrials.gov registry record · NA

UCLA Health Patient Cardiology Care Gaps

A NA study, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
46
Enrollment target

NCT06277323: Completed NA study, sponsored by University of California, Los Angeles.

NCT06277323 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06277323, a NA study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
46 participants
Enrollment target

Study Summary

This is a prospective randomized clinical trial evaluating how two behaviorally-informed interventions (i.e., monthly report card and storyboard interventions) impact physician behavior, with the goal of closing care gaps in preventive care and disease management. In particular, the monthly report card intervention seeks to elevate physicians' intentions to close their patients' care gaps, while the storyboard intervention seeks to prompt action by making patients' care gaps salient. The trial investigates the separate and joint impacts of the proposed behaviorally-informed interventions on encouraging physicians to close their patients' care gaps.

Primary Outcome

Whether a patient completed any of the following seven care gaps will be tracked for each patient who visits a physician during the first 12 months of the intervention period: (1) statin or PCSK9 inhibitor use, (2) aspirin use, (3) beta blocker use, (4) angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, or angiotensin receptor-neprilysin inhibitor use, (5) mineralocorticoid receptor antagonist use, (6) SGLT2i use, and (7) blood pressure control.

Interventions

  • BEHAVIORAL Monthly report card intervention
  • BEHAVIORAL Storyboard intervention

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2024-01-30
Est. Completion 2025-07-30
Phase NA

What the finished NCT06277323 record still lists

NCT06277323 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Monthly report card intervention is the first listed.

NCT06277323 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06277323 about?

NCT06277323 is a clinical study titled "UCLA Health Patient Cardiology Care Gaps". This is a prospective randomized clinical trial evaluating how two behaviorally-informed interventions (i.e., monthly report card and storyboard interventions) impact physician behavior, with the goal of closing care gaps in preventive care and disease management. In particular, the monthly report ...

What is the current status of trial NCT06277323?

This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2024-01-30. Estimated completion is 2025-07-30.

What interventions are being tested in trial NCT06277323?

The interventions under investigation include: Monthly report card intervention (BEHAVIORAL), Storyboard intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06277323?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06277323's enrollment target sits among peer trials

46 1402nd of 2000 higher than 590 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06277323, the US trial registry maintained by the National Library of Medicine. NCT06277323 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.